Thyroid disorders

1. High-Yield Summary

• Systemic thyroid dysfunction exerts profound regulatory effects on bone remodeling, soft-tissue biology, perioperative morbidity, and implant survival in musculoskeletal surgery.
• Hyperthyroidism drives high-turnover bone loss via RANKL-mediated osteoclast activation, shortening the bone remodeling cycle, preferentially depleting cortical bone (such as the distal radius), and increasing the risk of fragility fractures (hip fracture HR 1.61 to 3.6).
• Hypothyroidism causes hydrophilic glycosaminoglycan accumulation in the perineurium and joint capsules, predisposing patients to entrapment neuropathies (carpal tunnel syndrome) and adhesive capsulitis (frozen shoulder in up to 27%), while inducing low-turnover, adynamic bone with impaired collagen maturation.
• Elective orthopaedic reconstruction (total joint arthroplasty, spinal fusion) requires strict achievement of a clinical and biochemical euthyroid state (TSH 0.4 to 4.5 mIU/L); unmanaged hypothyroidism increases 90-day medical complications (OR 1.32) and prosthetic joint infections (OR 1.25).
• Differentiated thyroid carcinoma bone metastases are characteristically hypervascular, purely osteolytic, expansile lesions that mandate preoperative transarterial embolization within 24 to 48 hours prior to surgical stabilization or carcinologic resection to prevent catastrophic hemorrhage.

2. Anatomy

The thyroid gland is an endocrine organ situated in the anterior visceral compartment of the neck, deep to the sternohyoid and sternothyroid strap muscles, extending from the level of the fifth cervical vertebra (C5) to the first thoracic vertebra (T1). The gland consists of two lateral lobes connected across the midline by a vascular isthmus overlying the second through fourth tracheal rings. An understanding of its vascular architecture, neural relationships, and parathyroid anatomy is essential for anterior cervical spine approaches and oncologic resections.

The arterial supply originates from two major paired sources. The superior thyroid artery, the first anterior branch of the external carotid artery, descends to the superior pole in close anatomical proximity to the external branch of the superior laryngeal nerve. The inferior thyroid artery arises from the thyrocervical trunk of the subclavian artery, ascends retroperitoneally along the prevertebral fascia, and passes behind the carotid sheath to supply the inferior pole and the parathyroid glands. An anatomical variant, the thyroid ima artery, arises directly from the brachiocephalic trunk or aortic arch in 3% to 10% of the population, ascending along the anterior tracheal midline where it represents a danger zone during tracheostomy or lower cervical exposures. Venous drainage occurs via three paired systems: the superior and middle thyroid veins drain into the internal jugular vein, whereas the inferior thyroid veins drain caudally into the left brachiocephalic vein.

The recurrent laryngeal nerve (RLN), a major branch of the vagus nerve (cranial nerve X), supplies motor innervation to all intrinsic laryngeal muscles except the cricothyroid. The nerve exhibits marked asymmetry: the right RLN loops around the right subclavian artery and ascends obliquely within the tracheoesophageal groove, while the left RLN loops beneath the aortic arch at the ligamentum arteriosum and ascends vertically. During the anterior cervical spine approach (Smith-Robinson), retraction of the trachea, esophagus, and thyroid gland medially against the laterally retracted carotid sheath places the RLN at risk of traction neuropraxia. The right RLN is historically more vulnerable because of its more oblique trajectory and variable arborization before entering the larynx near the ligament of Berry.

Four parathyroid glands reside on the posterior capsule of the thyroid lobes, deriving their predominant vascular supply from branches of the inferior thyroid arteries. The parathyroid glands secrete parathyroid hormone (PTH), the primary systemic regulator of extracellular calcium and phosphate homeostasis. Parafollicular (C) cells located within the thyroid follicles synthesize calcitonin, a peptide hormone that directly inhibits osteoclastic bone resorption. Thyroid hormone receptors (TRalpha1 and TRbeta isoforms) are expressed on chondrocytes, osteoblasts, osteoclasts, skeletal muscle fibers, and synovial fibroblasts, linking systemic thyroid homeostasis to musculoskeletal tissue maintenance.

3. Pathogenesis

The pathophysiological manifestations of thyroid disorders in the musculoskeletal system span metabolic bone disease, soft-tissue matrix alterations, and metastatic osteolysis.

In hyperthyroidism (thyrotoxicosis), excess circulating free triiodothyronine (FT3) and free thyroxine (FT4) stimulate nuclear TRalpha1 receptors on osteoblasts. This signaling induces an upregulation of receptor activator of nuclear factor-kappa B ligand (RANKL) and downregulates osteoprotegerin (OPG), unleashing unrestrained osteoclast differentiation and activity. The normal bone remodeling cycle is accelerated and severely truncated: the resorption phase is shortened, but the osteoblastic formation phase is shortened even further, preventing complete refilling of resorption lacunae. This uncoupling results in a net negative bone balance, high-turnover osteoporosis, and an accelerated annual skeletal mass loss of up to 5% to 10%. Cortical bone is affected disproportionately compared to trabecular bone, leading to intracortical porosity, endosteal scalloping, and thinning of long bone diaphyses. Mild hypercalcemia and hypercalciuria occur in up to 20% of patients, suppressing endogenous parathyroid hormone and renal 1-alpha-hydroxylase activity, which further impairs intestinal calcium absorption.

In hypothyroidism, deficient thyroid hormone levels suppress cellular oxidative phosphorylation and protein metabolism throughout mesenchymal tissues. The hallmark soft-tissue alteration is the pathological accumulation of hydrophilic glycosaminoglycans (predominantly hyaluronic acid and chondroitin sulfate) within the interstitial matrix, synovial membranes, tendon sheaths, and peripheral nerve sheaths. In confined anatomical compartments, such as the carpal tunnel under the transverse carpal ligament, mucopolysaccharide deposition expands the flexor tenosynovium and induces endoneurial and perineurial edema, precipitating median nerve ischemia and entrapment neuropathy. Within synovial joint capsules, especially the glenohumeral joint, glycosaminoglycan accumulation triggers chronic low-grade inflammation, fibroblast proliferation, and dense collagen cross-linking (types I and III collagen), resulting in capsular thickening, volume contraction, and adhesive capsulitis. In osseous tissue, hypothyroidism induces an adynamic, low-turnover skeletal state. The remodeling cycle is prolonged from the normal 100 days to greater than 200 days, suppressing both resorption and formation. Mineralization is delayed, matrix collagen maturation is defective, and bone microdamage accumulates without normal repair, predisposing bone to fatigue microfractures, delayed fracture union, and pseudarthrosis.

Metastatic thyroid carcinoma exhibits a distinct osteotropic biology. Follicular thyroid carcinoma has a propensity for hematogenous dissemination to the skeleton, occurring in 10% to 20% of cases, while papillary carcinoma metastasizes to bone in approximately 2% to 5%. Tumor cells lodge in red marrow regions of the axial skeleton (spine, pelvis) and proximal long bones (femur, humerus). Metastatic cells secrete angiogenic mediators, including vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF), inducing extensive vascular proliferation, arteriovenous microfistulae, and sinusoidal engorgement. Concurrently, neoplastic cells secrete osteolytic cytokines (interleukin-6, parathyroid hormone-related protein, and RANKL) that stimulate osteoclastic bone resorption. This produces purely radiolucent, expansile, “blow-out” osteolytic lesions with complete absence of reactive osteoblastic bone formation, resulting in high rates of impending or completed pathological fractures and epidural cord compression.

4. Natural History

Thyroid disorders represent common endocrine conditions with a marked female predilection. Hypothyroidism affects 4% to 10% of the general population (subclinical in up to 8%, overt in 1% to 2%), with a female-to-male ratio of 5:1 to 8:1. Prevalence increases progressively with age, reaching up to 15% in women older than 60 years. Hyperthyroidism affects approximately 1.3% of women and 0.2% of men, caused most frequently by autoimmune Graves’ disease in younger individuals and toxic multinodular goiter or solitary toxic adenoma in elderly individuals.

Untreated hyperthyroidism leads to progressive skeletal demineralization, premature secondary osteoporosis, and a high incidence of fragility fractures. In prospective cohort studies, suppressed TSH levels (<0.10 mIU/L) are associated with a 1.6-fold to 3.6-fold increased risk of hip fracture and a 4.5-fold increase in new vertebral compression fractures in postmenopausal women. Even subclinical hyperthyroidism significantly increases hip and non-spine fracture risks. In untreated hypothyroidism, patients experience elevated fracture rates driven by neuromuscular weakness, impaired postural stability, bradykinesia, and brittle, adynamic bone matrix.

The natural history of adhesive capsulitis in patients with thyroid disease is notably protracted. While idiopathic frozen shoulder in euthyroid patients typically progresses through freezing, frozen, and thawing phases over 12 to 18 months, hypothyroid and hyperthyroid patients exhibit higher rates of bilateral involvement (up to 30%), prolonged symptomatic periods often exceeding 24 to 36 months, and greater resistance to nonoperative modalities.

In orthopaedic surgery, untreated thyroid dysfunction exerts an adverse prognostic impact. Large-scale database analyses demonstrate that pre-existing hypothyroidism increases 90-day medical complications (odds ratio 1.32), prosthetic joint infections (odds ratio 1.25), 90-day hospital readmissions (odds ratio 1.26), and surgical site wound complications following primary joint arthroplasty. In spinal fusion, untreated hypothyroidism correlates with increased nonunion rates. In metastatic thyroid cancer, untreated skeletal lesions lead to intractable pain, progressive spinal cord compression, pathological fractures, and severe reduction in median survival, whereas aggressive local surgical control combined with systemic therapy prolongs functional survival.

5. Clinical Presentation

History

Clinicians must maintain a high index of suspicion for underlying thyroid disorders when evaluating patients presenting with musculoskeletal complaints. A targeted clinical history should query both hypermetabolic and hypometabolic symptoms:

• Hyperthyroid symptoms: Heat intolerance, excessive sweating, resting palpitations, tremor, unexplained weight loss despite preserved or increased appetite, emotional lability, insomnia, and proximal muscle weakness (difficulty climbing stairs or rising from a low chair).
• Hypothyroid symptoms: Cold intolerance, chronic fatigue, lethargy, dry skin, coarsening hair, hoarseness, constipation, unexplained weight gain, periorbital puffiness, diffuse myalgias, arthralgias, nocturnal hand paresthesias, and progressive stiffness of the shoulders.
• Endocrine and oncologic history: History of goiter, thyroid nodules, neck radiation therapy, radioactive iodine (I-131) ablation, total or partial thyroidectomy, or differentiated thyroid cancer. Inquire about compliance with thyroid hormone replacement (levothyroxine) or anti-thyroid medications (methimazole, propylthiouracil), and exposure to thyroid-altering agents such as amiodarone, lithium, or immune checkpoint inhibitors.
• Skeletal pain characteristics: Deep, aching bone pain localized to the spine, pelvis, or proximal long bones that is unremitting, awakens the patient from sleep, or is aggravated by weight-bearing suggests an impending pathological fracture or osteolytic metastasis.

Physical Exam

Physical examination must integrate targeted endocrine assessment with rigorous provocative musculoskeletal testing:

• Phalen Test (Carpal Tunnel Syndrome): [Technique: Patient maintains maximal active or passive wrist flexion for 60 seconds with forearms held in neutral rotation] -> Reproduction of tingling, paresthesias, or numbness in the median nerve distribution [Sensitivity 68-73%, Specificity 73-86%]
• Tinel Sign (Median Nerve at Wrist): [Technique: Gentle percussive tapping directly over the volar carpal tunnel at the proximal wrist crease] -> Electric shock-like sensations radiating into the thumb, index, long, and radial half of the ring finger [Sensitivity 50-60%, Specificity 77-87%]
• Durkan Carpal Compression Test: [Technique: Direct thumb pressure applied over the transverse carpal ligament at the volar wrist for 30 seconds] -> Reproduction of median nerve paresthesias or numbness [Sensitivity 87-89%, Specificity 90-96%]
• Passive External Rotation Deficit (Adhesive Capsulitis): [Technique: Examiner stabilizes the scapula and passively measures external rotation with the arm at 0 degrees abduction, comparing to the contralateral side] -> Loss of passive external rotation greater than 50% or greater than 30 degrees reduction compared to the unaffected shoulder with a firm, mechanical end-feel [Sensitivity 88-92%, Specificity 90-95%]
• Proximal Muscle Power Testing (Thyroid Myopathy): [Technique: Manual muscle testing of hip flexors (iliopsoas) and shoulder abductors (deltoid) against maximal examiner resistance, along with an unassisted chair rise test] -> Inability to rise from a standard chair without arm assistance or Medical Research Council (MRC) grade 3-4/5 strength without primary sensory deficits [Sensitivity 75-80%, Specificity 82-88%]
• Chvostek Sign (Post-Surgical Hypocalcemia): [Technique: Gentle percussion over the facial nerve trunk anterior to the external auditory meatus and inferior to the zygomatic arch] -> Ipsilateral twitching of the circumoral and facial musculature [Sensitivity 27-30%, Specificity 95-98%]
• Trousseau Sign (Latent Tetany / Hypocalcemia): [Technique: Sphygmomanometer cuff inflated to 20 mmHg above systolic blood pressure for 3 minutes] -> Carpopedal spasm characterized by wrist and metacarpophalangeal flexion, interphalangeal extension, and thumb adduction [Sensitivity 94-96%, Specificity 98-99%]
• Neck and General Examination: Palpation of the thyroid bed for goiter, discrete nodules, or prior anterior surgical scars; evaluation of resting tremor, periorbital edema, exophthalmos, pretibial myxedema, and deep tendon reflexes (delayed relaxation phase in hypothyroidism).

6. Imaging and Diagnostic Studies

Diagnostic evaluation encompasses plain radiographs, dual-energy x-ray absorptiometry, magnetic resonance imaging, functional nuclear scintigraphy, and targeted biochemical assays:

Plain Radiography: Radiographs of the skeleton in hyperthyroidism reveal generalized osteopenia, endosteal resorption, cortical striations, and progressive thinning of the cortices. A pathognomonic finding of autoimmune Graves’ disease is thyroid acropachy, which appears as fluffy, feathery, or spiculated periosteal new bone formation along the diaphyses of the metacarpals, metatarsals, and proximal phalanges, strictly sparing the epiphyses and articular surfaces. In skeletal metastases from follicular or papillary thyroid carcinoma, plain radiographs demonstrate destructive, geographic, purely radiolucent, expansile “blow-out” osteolytic lesions with complete cortical disruption and a total absence of reactive osteoblastic sclerosis.

Dual-Energy X-Ray Absorptiometry (DXA): Central DXA evaluation should include the lumbar spine (L1–L4), total hip, femoral neck, and the non-dominant 33% (distal one-third) radius. Because the distal radius consists of greater than 95% cortical bone, it is the most sensitive skeletal site for detecting high-turnover bone loss driven by thyrotoxicosis. A T-score of -2.5 or lower defines osteoporosis, while serial scans performed every 12 to 24 months assess skeletal recovery following endocrine normalization.

Magnetic Resonance Imaging (MRI): In adhesive capsulitis, shoulder MRI demonstrates thickening of the coracohumeral ligament (greater than 4 mm), thickening of the glenohumeral joint capsule at the axillary pouch (greater than 4 mm), hyperintense capsular edema on T2-weighted and proton density-weighted fat-suppressed sequences, and obliteration of the subcoracoid fat triangle. In metastatic thyroid disease, MRI reveals marked hypointensity on T1-weighted images, hyperintensity on T2-weighted and STIR sequences, and intense heterogeneous contrast enhancement following gadolinium administration; high-velocity flow voids within the tumor mass indicate hypervascularity.

Nuclear Scintigraphy and Functional Imaging: Technetium-99m methylene diphosphonate (Tc-99m MDP) bone scintigraphy can produce false-negative photopenic (cold) scans in purely lytic thyroid metastases due to lack of reactive osteoblastic activity. Iodine-131 (I-131) and Iodine-123 (I-123) whole-body scintigraphy are the gold standards for detecting functional differentiated thyroid cancer metastases that retain sodium-iodide symporter (NIS) expression. Fluorodeoxyglucose (18F-FDG) PET-CT is indicated for poorly differentiated or non-iodine-avid skeletal metastases to assess overall disease burden.

Laboratory Evaluation:

• Serum Thyroid-Stimulating Hormone (TSH): The primary screening assay (reference range: 0.4 to 4.0 mIU/L). Suppressed levels (4.5 mIU/L) indicate hypothyroidism.
• Free Thyroxine (FT4, 0.8 to 1.8 ng/dL) and Free Triiodothyronine (FT3, 2.3 to 4.2 pg/mL): Differentiate overt from subclinical dysfunction and monitor therapeutic replacement.
• Thyroid Autoantibodies: Anti-thyroid peroxidase (anti-TPO) and anti-thyroglobulin (anti-Tg) confirm Hashimoto’s thyroiditis; thyroid-stimulating immunoglobulin (TSI) or TSH-receptor antibody (TRAb) confirms Graves’ disease.
• Serum Calcium, Albumin, Phosphate, and Intact PTH: Mandatory assessment following total thyroidectomy to diagnose inadvertent hypoparathyroidism or rule out concomitant hyperparathyroidism.
• Bone Turnover Markers: Bone-specific alkaline phosphatase (BSAP) and serum C-telopeptide of type I collagen (CTX) monitor the high-turnover bone resorption of thyrotoxicosis.
• Serum Thyroglobulin (Tg): Sensitive tumor marker for surveillance following total thyroidectomy; rising levels indicate recurrent or metastatic disease.

7. Classification

Thyroid disorders impacting the musculoskeletal system are classified according to functional endocrine status, autoimmune manifestations, and oncologic bone involvement, directly dictating clinical and surgical management:

8. Treatment

Medical / Nonoperative

The primary nonoperative objective in all thyroid disorders is the restoration and maintenance of a biochemical and clinical euthyroid state:

• Endocrine Optimization in Hypothyroidism: Synthetic levothyroxine (T4) replacement is administered at a weight-based maintenance dose of 1.6 mcg/kg/day in young, healthy adults. In elderly patients or those with coronary artery disease, initiate therapy cautiously at 25 to 50 mcg/day to avoid precipitating cardiac ischemia. Serum TSH is reassessed every 6 to 8 weeks, adjusting dosage by 12.5 to 25 mcg increments until TSH normalizes within the target therapeutic window (0.5 to 2.5 mIU/L).
• Endocrine Optimization in Hyperthyroidism: Antithyroid thionamides (methimazole 10 to 30 mg daily; propylthiouracil reserved for first-trimester pregnancy and thyroid storm) block thyroid peroxidase and hormone synthesis. Non-selective beta-adrenergic antagonists (propranolol 20 to 40 mg every 6 to 8 hours) provide immediate symptom relief, controlling resting tachycardia, tremor, and agitation, while partially inhibiting peripheral conversion of T4 to T3. Definitive control is achieved via radioactive iodine (I-131) ablation or near-total thyroidectomy.
• Bone-Targeted Antiresorptive Therapy: For thyrotoxic osteoporosis, bisphosphonates (oral alendronate 70 mg weekly or intravenous zoledronic acid 5 mg annually) or the RANKL inhibitor denosumab (60 mg subcutaneously every 6 months) effectively arrest rapid osteoclastic resorption, normalize bone turnover markers, and preserve bone density during the thyrotoxic recovery phase. For metastatic bone disease, high-dose denosumab (120 mg subcutaneously every 4 weeks) or zoledronic acid (4 mg intravenously every 4 weeks) significantly reduces skeletal-related events (pathological fractures, spinal cord compression, radiation to bone).
• Nonoperative Management of Musculoskeletal Manifestations: For carpal tunnel syndrome in thyroid disease, conservative management consists of nocturnal neutral volar wrist splinting, activity modification, and local corticosteroid injections (triamcinolone acetonide 20 to 40 mg). Complete resolution of median nerve symptoms occurs in over 60% of hypothyroid patients within 3 to 6 months of achieving a euthyroid state without requiring surgical decompression. For adhesive capsulitis, nonoperative treatment includes supervised physical therapy emphasizing pain-free active-assisted and passive stretching, combined with early intra-articular glenohumeral corticosteroid injection (triamcinolone acetonide 40 mg with 1% lidocaine) to alleviate synovitis and expedite functional range-of-motion recovery.

Operative

The primary goals of surgery in thyroid-related musculoskeletal conditions are neural decompression, joint mobilization, rigid stabilization of impending or established pathological fractures, and carcinologic oncologic resection:

• Carpal Tunnel Release: Open or endoscopic transverse carpal ligament release is indicated when conservative measures fail, or when electrodiagnostic studies demonstrate severe axonal loss, persistent denervation (fibrillations and positive sharp waves), or progressive thenar muscle atrophy. In hypothyroid patients, surgery should generally be deferred for 3 to 6 months while levothyroxine is titrated, unless progressive motor deficits supervene.
• Adhesive Capsulitis Surgical Release: When structured physical therapy and intra-articular injections fail after 6 to 9 months of treatment, closed manipulation under anesthesia (MUA) and arthroscopic capsular release are indicated. Arthroscopic release involves a systematic 360-degree capsular division: release of the rotator interval and coracohumeral ligament, anterior capsule down to the 6 o’clock position, and posterior capsule from 8 to 12 o’clock. The inferior pouch must be divided close to the glenoid labrum to protect the axillary nerve. Immediate postoperative physical therapy with continuous passive motion is instituted on postoperative day zero.
• Surgical Management of Skeletal Metastases: For solitary, resectable thyroid cancer bone metastases in patients with controlled primary disease, carcinologic en bloc resection with wide margins followed by modular endoprosthetic reconstruction offers long-term disease-free and overall survival benefits. For impending or actual pathological fractures of long bones, rigid internal fixation utilizing intramedullary nails or locked plates augmented with polymethylmethacrylate (PMMA) bone cement provides immediate load-sharing stability. Because of extreme neoangiogenesis and arteriovenous shunts, selective transarterial catheter embolization (using coils, particles, or liquid embolic agents) is mandatory within 24 to 48 hours preoperatively to mitigate massive intraoperative blood loss. In spinal metastases with cord compression, circumferential decompression and rigid multi-level pedicle screw instrumentation are performed.
• Total Joint Arthroplasty Considerations: In patients undergoing elective primary hip or knee arthroplasty with a history of thyroid disorders, cemented implant fixation is preferred in osteopenic thyrotoxic or adynamic hypothyroid bone to ensure primary stability and reduce periprosthetic fracture and subsidence risks. Meticulous soft-tissue handling and rigorous hemostasis are mandatory.

Indications & Contraindications

Specific numerical thresholds and clinical parameters dictate surgical decision-making:

• TSH Thresholds for Elective Surgery: Elective orthopaedic and spine surgery is strictly contraindicated in overt hypothyroidism (serum TSH >10.0 mIU/L with low Free T4) and overt hyperthyroidism (serum TSH <0.10 mIU/L with elevated Free T4/T3). Elective surgery should proceed only when a verified euthyroid state is achieved (serum TSH 0.4 to 4.5 mIU/L). For subclinical hypothyroidism (TSH 4.5 to 10.0 mIU/L with normal Free T4), elective surgery may proceed with close postoperative clinical monitoring.
• Mirels Score for Impending Pathological Fracture: Skeletal metastatic lesions with a Mirels score of 8 or greater represent an indication for prophylactic internal fixation or endoprosthetic reconstruction prior to radiotherapy or systemic treatment.
• Indications for Urgent/Emergent Intervention: Epidural spinal cord compression with progressive motor deficit from metastatic thyroid cancer warrants emergent surgical decompression and stabilization within 24 to 48 hours regardless of baseline thyroid status, accompanied by aggressive perioperative medical stabilization. Orthopaedic trauma (femoral neck fracture, displaced shaft fracture) in an unoptimized patient requires urgent fixation following stabilization with beta-blockers, antithyroid agents, or stress-dose steroids.
• Contraindications to Invasive Intervention: Non-embolized hypervascular thyroid bone metastases represent a relative contraindication to open elective curettage or stabilization due to the risk of life-threatening hemorrhage; embolization must precede surgery. Extensive multi-organ metastatic burden with short life expectancy (<3 months) contraindicates extensive carcinologic en bloc resections, favoring minimally invasive palliative percutaneous stabilization or radiotherapy.

9. Outcome

Clinical outcomes in thyroid-related musculoskeletal disorders depend on endocrine optimization, timely intervention, and surgical technique:

• Patient-Reported Outcome Measures (PROMs): In patients undergoing arthroscopic capsular release for refractory adhesive capsulitis, American Shoulder and Elbow Surgeons (ASES) scores improve from a preoperative mean of 34 to 38 points to greater than 82 points at 1-year follow-up. Mean passive forward flexion increases from 95 degrees to 155 degrees, while passive external rotation improves from 15 degrees to 48 degrees. In carpal tunnel release, Boston Carpal Tunnel Questionnaire (BCTQ) symptom severity scores improve from a mean of 3.4 preoperatively to 1.3 postoperatively, with rapid normalization of median nerve sensory latencies.
• Reversal of Fracture Risk: Normalization of thyroid status in hyperthyroidism halts high-turnover bone loss. Longitudinal studies demonstrate that bone mineral density increases by 4% to 8% at the lumbar spine and hip within 12 to 24 months after achieving euthyroidism, with incident fracture risks declining back toward age-matched cohort baselines over 2 to 3 years.
• Arthroplasty Implant Survivorship: Medically optimized hypothyroid patients achieve 10-year prosthetic joint survivorship comparable to euthyroid controls (94% vs 95%). Conversely, uncontrolled hypothyroid cohorts experience higher 90-day revision, infection, and periprosthetic fracture rates.
• Skeletal Metastasis Survivorship: In solitary bone metastases from differentiated thyroid cancer, complete R0 carcinologic resection achieves 5-year and 10-year overall survival rates of 78% and 53%, respectively. In contrast, patients with disseminated skeletal metastases managed palliatively have a median survival of 24 to 36 months, highlighting the value of en bloc resection in oligometastatic presentations.

10. Complications

Complications associated with thyroid disorders in orthopaedic surgery are categorized by timing, underlying pathophysiology, and management strategies:

11. Pearls and Pitfalls

Clinical and Surgical Pearls:

• Screen for Thyroid Dysfunction in Frozen Shoulder: Routine TSH screening is indicated in any patient presenting with idiopathic, recalcitrant, or bilateral adhesive capsulitis, as up to 27% have underlying thyroid dysfunction.
• Conservative Trial for Carpal Tunnel in Hypothyroidism: Resist immediate surgical release in mild to moderate carpal tunnel syndrome associated with newly diagnosed or unoptimized hypothyroidism; approximately 60% of patients achieve complete symptom resolution following 3 to 6 months of levothyroxine replacement.
• Cortical Bone Surveillance: Always evaluate the distal 33% radius on DXA in patients with a history of thyrotoxicosis or long-term suppressive levothyroxine therapy, as preferential cortical loss may be obscured by normal trabecular spine BMD.
• Endotracheal Cuff Pressure Monitoring: During anterior cervical spine approaches, always deflate and reinflate the endotracheal cuff after retractor placement to reduce the incidence of postoperative recurrent laryngeal nerve neuropraxia.
• Preoperative Embolization of Thyroid Metastases: Never biopsy or operate on an expansile osteolytic bone lesion suggestive of metastatic thyroid cancer without cross-sectional contrast imaging and planned preoperative arterial embolization within 24 to 48 hours of surgery.

Clinical and Judgment Pitfalls:

• Operating in Overt Hypothyroidism: Proceeding with elective total joint arthroplasty in a patient with a TSH greater than 10.0 mIU/L significantly escalates 90-day medical complications, wound breakdown, and periprosthetic infection.
• Relying Solely on Bone Scans for Thyroid Metastases: Technetium-99m bone scans can be falsely negative or cold in purely lytic follicular thyroid metastases; rely on functional iodine scintigraphy (I-131/I-123) or PET-CT in high-risk patients.
• Ignoring Post-Thyroidectomy Hypocalcemia: Inadvertent devascularization or excision of parathyroid glands during thyroidectomy can produce severe latent hypocalcemia; failing to verify serum calcium and intact PTH prior to elective orthopaedic surgery risks intraoperative tetany and cardiac arrhythmias.
• Overzealous Arthroscopic Capsular Release: Dividing the inferior capsule too far down the humeral neck during arthroscopic capsular release risks iatrogenic transection of the axillary nerve; maintain the capsulotomy immediately adjacent to the glenoid labrum.

12. Controversy

Controversy 1: TSH Suppression Targets in Thyroid Cancer vs. Long-Term Fracture Risk. Following thyroidectomy for differentiated thyroid carcinoma, supra-physiological levothyroxine therapy is traditionally administered to suppress TSH (often to <0.10 mIU/L) to prevent tumor recurrence. However, cumulative data confirm that prolonged iatrogenic TSH suppression accelerates cortical bone loss, doubles the risk of fragility fractures, and increases cardiovascular mortality in postmenopausal women. Modern consensus guidelines increasingly advocate for risk-stratified TSH suppression: maintaining TSH between 0.1 and 0.5 mIU/L for intermediate-risk disease and allowing normalization to 0.5 to 2.0 mIU/L for low-risk, disease-free patients, with proactive antiresorptive therapy in patients at high risk of osteoporotic fracture.

Controversy 2: Universal vs. Selective TSH Screening in Idiopathic Adhesive Capsulitis. While up to 27% of patients presenting with idiopathic frozen shoulder have diagnosed or occult hypothyroidism, controversy persists regarding whether universal laboratory screening of TSH is cost-effective. Advocates argue that early detection allows timely endocrine replacement, mitigates systemic morbidity, and may improve shoulder rehabilitation timelines. Skeptics note that restoring euthyroidism does not immediately reverse capsular fibrosis once advanced cross-linking has occurred, and argue that screening should be reserved for patients with bilateral presentation, constitutional symptoms, or resistance to initial physical therapy.

Controversy 3: Timing of Elective Arthroplasty in Subclinical Hypothyroidism. When a patient awaiting elective total joint replacement presents with subclinical hypothyroidism (TSH 4.5 to 10.0 mIU/L with normal Free T4), clinical debate centers on whether surgery should be postponed for 6 to 8 weeks for levothyroxine initiation and titration versus proceeding without delay. While large registry data demonstrate increased complications in overt hypothyroidism, subclinical hypothyroidism has not consistently been linked to elevated periprosthetic infection or catastrophic perioperative collapse. Current multidisciplinary consensus supports proceeding with elective arthroplasty in asymptomatic subclinical hypothyroidism (TSH <10.0 mIU/L), with concurrent endocrine referral and postoperative levothyroxine titration.

13. Evidence-Based Synthesis

Modern clinical decision-making is grounded in high-quality randomized controlled trials and prospective registry analyses, corroborated by seminal biomechanical and anatomical descriptions.

14. References

• Blum MR, Bauer DC, Collet TH et al. Subclinical thyroid dysfunction and fracture risk: a meta-analysis. JAMA. 2015. doi:10.1001/jama.2015.5161 [Level I: Systematic Review / Meta-Analysis]
• Bauer DC, Ettinger B, Nevitt MC et al. Risk for fracture in women with low serum levels of thyroid-stimulating hormone. Ann Intern Med. 2001. doi:10.7326/0003-4819-134-7-200104030-00009 [Level II: Prospective Cohort Study (Study of Osteoporotic Fractures)]
• Schiefer M, Teixeira PFS, Fontenelle C et al. Prevalence of hypothyroidism in patients with frozen shoulder. J Shoulder Elbow Surg. 2017. doi:10.1016/j.jse.2016.04.026 [Level III: Comparative Case-Control Study]
• Buller LT, Rosas S, Sabeh KG et al. Hypothyroidism Increases 90-Day Complications and Costs Following Primary Total Knee Arthroplasty. J Arthroplasty. 2018. doi:10.1016/j.arth.2017.10.053 [Level III: Retrospective Comparative Cohort Study (PearlDiver Database)]
• Fragnaud H, Mattei JC, Le Nail LR et al. Mid and long-term overall survival after carcinologic resections of thyroid cancer bone metastases. Front Surg. 2022. doi:10.3389/fsurg.2022.965951 [Level IV: Retrospective Multicenter Surgical Cohort Study]

15. Master Class Pro-Tip

Rigorous preoperative endocrine optimization is a mandatory prerequisite for elective orthopaedic reconstruction. In patients with known or occult thyroid dysfunction, a serum TSH level must be confirmed within the euthyroid range (0.4–4.5 mIU/L) prior to elective total joint arthroplasty or spinal instrumentation. Proceeding with elective reconstructive procedures in the presence of uncorrected overt hypothyroidism (TSH >10.0 mIU/L) increases the risk of periprosthetic infection, wound breakdown, and delayed bone healing, whereas uncorrected thyrotoxicosis risks catastrophic intraoperative thyroid storm. When dealing with skeletal metastases from follicular or papillary thyroid carcinoma, the single most critical surgical error is undertaking biopsy or open stabilization without prior cross-sectional contrast imaging and angiography; these lesions are intensely hypervascular and mandate transarterial coil or particle embolization within 24 to 48 hours preoperatively to prevent life-threatening intraoperative exsanguination.

Master Class Surgical Pearl: Preoperative Endocrine Optimization in Musculoskeletal Surgery